Suppr超能文献

为基因组医学建立证据并衡量临床结果。

Building evidence and measuring clinical outcomes for genomic medicine.

机构信息

Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.

出版信息

Lancet. 2019 Aug 17;394(10198):604-610. doi: 10.1016/S0140-6736(19)31278-4. Epub 2019 Aug 5.

Abstract

Human genomic sequencing has potential diagnostic, prognostic, and therapeutic value across a wide breadth of clinical disciplines. One barrier to widespread adoption is the paucity of evidence for improved outcomes in patients who do not already have an indication for more focused testing. In this Series paper, we review clinical outcome studies in genomic medicine and discuss the important features and key challenges to building evidence for next generation sequencing in the context of routine patient care.

摘要

人类基因组测序在广泛的临床学科中具有潜在的诊断、预后和治疗价值。广泛采用的一个障碍是,对于那些已经没有更有针对性的检测指征的患者,缺乏改善预后的证据。在本系列论文中,我们回顾了基因组医学中的临床结果研究,并讨论了在常规患者护理背景下建立下一代测序证据的重要特征和关键挑战。

相似文献

1
Building evidence and measuring clinical outcomes for genomic medicine.为基因组医学建立证据并衡量临床结果。
Lancet. 2019 Aug 17;394(10198):604-610. doi: 10.1016/S0140-6736(19)31278-4. Epub 2019 Aug 5.
2
Enabling Precision Oncology Through Precision Diagnostics.通过精准诊断实现精准肿瘤学。
Annu Rev Pathol. 2020 Jan 24;15:97-121. doi: 10.1146/annurev-pathmechdis-012418-012735.
7
[Genomic medicine].[基因组医学]
Ugeskr Laeger. 2019 Apr 1;181(7A).
10
High-throughput sequencing technologies.高通量测序技术
Mol Cell. 2015 May 21;58(4):586-97. doi: 10.1016/j.molcel.2015.05.004.

引用本文的文献

本文引用的文献

7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验